Plain-English translation of NCT05745285 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Leukemia research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether services provided by Blood Cancer United—including information, financial aid, and care navigation—help patients with blood cancers like leukemia, lymphoma, and myeloma feel better, access care more easily, and manage costs. Some participants will receive these support services along with their regular medical care, while others will receive standard care alone. The study will follow both groups for 6 months to compare their quality of life, healthcare access, and financial stress.
Many patients with blood cancers struggle with costs, finding specialists, and emotional stress—but we don't yet have solid evidence about how well patient advocacy services actually help. This study will measure whether these support programs make a real difference in how patients feel and whether they can get the care they need.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to either receive the support services from Blood Cancer United (such as financial assistance, information, and help accessing care) along with your regular medical care, or to receive your usual care alone. For 6 months, you will complete surveys and check-ins so researchers can track how you're doing, how well you can access care, and how much financial burden you're experiencing. You may also share medical records to help the study team understand your treatment journey.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States